购物车
- 全部删除
- 您的购物车当前为空
PTA001_A4 (Anti-CDH17/Cadherin-17 Antibody) 是一种靶向 CDH17/Cadherin-17 的人源化抗体,具有潜在的抗肿瘤活性,抑制肿瘤细胞生长,可用于研究癌症。
为众多的药物研发团队赋能,
让新药发现更简单!
PTA001_A4 (Anti-CDH17/Cadherin-17 Antibody) 是一种靶向 CDH17/Cadherin-17 的人源化抗体,具有潜在的抗肿瘤活性,抑制肿瘤细胞生长,可用于研究癌症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,300 | 现货 | |
5 mg | ¥ 3,250 | 现货 | |
10 mg | ¥ 4,750 | 现货 | |
25 mg | ¥ 7,480 | 现货 | |
50 mg | ¥ 9,870 | 现货 |
产品描述 | PTA001_A4 (Anti-CDH17/Cadherin-17 Antibody) is a humanized antibody targeting CDH17/Cadherin-17 with potential anti-tumor activity, inhibits the growth of tumor cells, and can be used for cancer research. |
别名 | Anti-CDH17/Cadherin-17 Antibody |
存储 | store at low temperature | store at -20°C | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容